Global Bioprocess Integrity Testing systems market demand is anticipated to be valued at USD 74.2 Million in 2022, forecast to grow at a CAGR of 5.7% to be valued at USD 136.6 Million from 2022 to 2032. Growth is attributed to increasing the availability of fully automated integrity test systems. From 2016-2021 a CAGR of 5.0% was registered for the biscuit mixes market.
| Report Attribute | Details |
|---|---|
| Projected Growth Rate (2022 to 2032) | 5.7% CAGR |
| Expected Market Value (2022) | USD 74.2 Million |
| Anticipated Forecast Value (2032) | USD 136.6 Million |
Many multi-national companies are focusing on new product innovations and are required to follow the GMP guidelines which is the most critical factor in bioprocess Integrity Testing systems These factors contribute to the bioprocess Integrity Testing systems market.
In the manufacturing of sterile drug products, it is critical to access filter Bioprocess Integrity Testing as regulated by regulatory bodies. The filter in the bioprocess is subjected to wear owing to particle load, fluctuations in pressure and temperature, changes in pH, and other factors. The performance of filter elements is crucial in any bioprocess.
Pressure hold testing, bubble point testing, and diffusive flow testing are some of the examples of filter integrity tests. Out of these, the bubble point test is considered simple, economical, and comes with easy applicability.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing awareness about the benefits of using the Bioprocess Integrity Testing systems market among healthcare professionals and consumers fuelling the demand for the Bioprocess Integrity Testing systems market. Technological advancements in filter design and manufacturing improve performance, and the increasing availability of fully automated integrity test systems will boost the growth of the market in the forecasting period.
Due to the reliability of the systems, portability, and ease of implementation Bioprocess Integrity Testing is adopted by leading biopharmaceutical players and biotechnology companies. The market for bioprocess Integrity Testing systems would be accelerated due to the accelerated testing capabilities of the systems.
Although the Bioprocess Integrity Testing system market has numerous end-uses, there are numerous obstacles that likely pose a challenge to market growth. Lack of technical expertise and lack of awareness in the developing and underdeveloped economies may impede the growth of the Bioprocess Integrity Testing system market. The High cost associated with testing may also hider the growth of the Bioprocess Integrity Testing system market.
Principal Consultant
North America was the largest market for the Bioprocess Integrity Testing system market and the trend is expected to continue into the forecast period owing to the increasing government support and increasing R&D activities.
The technological advancement in the healthcare sector in the region is expected to augment the Bioprocess Integrity Testing system market. The region is forecast to have a 33.0% total share of the Bioprocess Integrity Testing system market.
North America is expected to be the next dominant region witnessing high adoption rates for the Bioprocess Integrity Testing system market during the forecast period due to the increasing demand for biopharmaceuticals and the implementation of drug safety guidelines by the FDA.
According to Future Market Insights Europe accounts for a total 30.0% share in the global Bioprocess Integrity Testing system market. Increasing healthcare investments and the presence of prominent market vendors and providers also benefit Europe’s market.
The global Bioprocess Integrity Testing system market is gaining traction in the region due to increasing research facilities and the developing biopharmaceutical industry and the growth in the biologics market. Also, stringent government guidelines for purity requirements in pharmaceutical and biotechnology manufacturing boost the growth of the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Bugworks Research, Medgenome, BitBio, uFraction, Tasi Group and vertex-scientific-lab-instruments-co-company are some start-up companies operating in the Bioprocess Integrity Testing system market.
Some of the key participants present in the global Bioprocess Integrity Testing system market include Merck Millipore, Eurofins Scientific, Pall Corporation, Sartorius Group, and Viet Anh Scientific Co., Ltd. among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Merck Millipore, Eurofins Scientific, Pall Corporation account for considerable market size, several regional level players are also operating across key growth regions, particularly in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.7% from 2022 to 2032 |
| Expected Market Value (2022) | USD 74.2 Million |
| Anticipated Forecast Value (2032) | USD 136.6 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Process Type, End User, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, GCC, South Africa, Israel |
| Key Companies Profiled | Merck Millipore; Eurofins Scientific; Pall Corporation; Sartorius Group; Viet Anh Scientific Co. Ltd. |
| Customization | Available Upon Request |
FMI projects the global Bioprocess Integrity Testing system market to expand at a 5.7% value CAGR by 2032.
North America is expected to be the most opportunistic with a 33.0% share of the total Bioprocess Integrity Testing system market.
Merck Millipore, Eurofins Scientific, Pall Corporation are some prominent Bioprocess Integrity Testing system market manufacturers.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Types 5.1. Destructive Testing 5.2. Non-Destructive Testing 5.3. Bubble Point Testing 5.4. Diffusion Testing 5.5. Pressure Hold Testing 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Process Types 6.1. Particle-Based 6.2. Liquid Property Based 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End Users 7.1. Biopharmaceutical Industry 7.2. Biotechnology Industry 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. MEA 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Merck Millipore 16.2. Eurofins Scientific 16.3. Pall Corporation 16.4. Sartorius Group 16.5. Viet Anh Scientific Co., Ltd. 17. Assumptions & Acronyms Used 18. Research Methodology
Healthcare
January 2023
REP-GB-13912
309 pages
Explore Healthcare Insights
View Reports
Bioprocess Integrity Testing Systems Market
